Form 4: IGM Biosciences Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mary Beth Harler, Head of Research & Autoimmunity at IGM Biosciences, sold 1,570 shares of common stock to cover tax withholding obligations.
Summary
- On June 14, 2024, Mary Beth Harler, Head of Research & Autoimmunity at IGM Biosciences, sold 1,570 shares of IGM Biosciences common stock.
- The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units.
- The shares were sold at a weighted average price of $7.5753, with individual trades ranging from $7.26 to $7.94.
- Following the transaction, Harler directly owns 85,227 shares of IGM Biosciences common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive selling shares to cover taxes is a common occurrence and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations related to stock vesting. The impact on the overall market and IGM Biosciences is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of the stock sale transaction. |
| 06/18/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.